Submitted by Anonymous (not verified) on 19 September 2024 - 11:46
Opinion/decision on a Paediatric investigation plan (PIP): Ultomiris, ravulizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Uro-nephrology, PIP number: P/0379/2023
Source: